CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell Malignancies

Martyniszyn, Alexandra; Krahl, Ann-Christin; Andre, Maya C.; Hombach, Andreas A.; Abken, Hinrich

dc.contributor.author	Krahl, Ann-Christin
dc.contributor.author	André, Maya C.
dc.date.accessioned	2019-04-01T06:54:50Z
dc.date.available	2019-04-01T06:54:50Z
dc.date.issued	2017
dc.identifier.issn	1557-7422
dc.identifier.uri	http://hdl.handle.net/10900/87349
dc.language.iso	en	de_DE
dc.publisher	Mary Ann Liebert	de_DE
dc.relation.uri	http://dx.doi.org/10.1089/hum.2017.126	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell Malignancies	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_00168
utue.publikation.seiten	1147-1157	de_DE
utue.personen.roh	Martyniszyn, Alexandra
utue.personen.roh	Krahl, Ann-Christin
utue.personen.roh	Andre, Maya C.
utue.personen.roh	Hombach, Andreas A.
utue.personen.roh	Abken, Hinrich
dcterms.isPartOf.ZSTitelID	Human Gene Therapy	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	28	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE